Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.
Research published in the April print edition of the journal Life Science Alliance, shows that antidepressant drugs called FIASMAs, including desipramine, amitriptyline, and nortriptyline, halt the growth or kill four different intracellular bacterial pathogens in tissue cell culture and animal models.
“Antibiotic options for diseases caused by intracellular bacteria are limited because many of these drugs cannot penetrate our cell membranes. In essence, the bacteria are protected,” said Jason Carlyon, Ph.D., leader of the study and professor in the VCU Department of Microbiology and Immunology.
Tetracycline antibiotics are most commonly prescribed to treat intracellular bacterial infections because they can cross cell membranes to reach the microbes. However, tetracyclines can cause allergic reactions in some patients and physicians advise against their use by pregnant women and children due to undesirable side effects. Additionally, antibiotic resistance in some intracellular bacteria has been reported.
“It would be highly beneficial to have a class of drugs to treat such diseases in patients for whom tetracyclines are contraindicated,” Carlyon said. “These drugs could provide an alternative to antibiotics or even be used in conjunction with them as an augmentation approach to treat infections that typically require prolonged courses of antibiotic therapy, such as those caused by Chlamydia pneumoniae and Coxiella burnetti.”
The team of researchers from VCU, Indiana University Medical Center, University of Nebraska Medical Center, University of Arkansas for Medical Sciences, and the University of South Florida, including Carlyon and lead author Chelsea Cockburn, an M.D.-Ph.D. candidate, are the first to investigate the mechanisms by which FIASMAs target multiple intracellular bacteria in detail.
The scientists tested FIASMA susceptibility for four bacterial species that cause human granulocytic anaplasmosis, a tick-borne disease that attacks white blood cells called neutrophils and can be fatal to immune compromised individuals; Q fever, a debilitating pneumonic disease; and two chlamydia infections.
FIASMAs ultimately disrupt how cholesterol, a key nutrient utilized by many intracellular pathogens, traffics inside cells to alter bacterial access to the lipid. The researchers first proved FIASMA treatment efficacy by halting anaplasmosis in both tissue culture and mice. Next, they extended their observations to demonstrate that FIASMA treatment killed the Q fever agent,Coxiella burnetii, and partially inhibited chlamydial infections in cell culture.
“Since FIASMAs influence cholesterol trafficking in the cell and cholesterol plays a role in so many facets of our biology, they have been used to treat a wide variety of conditions and diseases,” Carlyon said.
He added that the effect of FIASMAs on intracellular cholesterol ultimately bypasses the need to directly target the bacteria.
“What is so exciting about this study is that the class of drugs we evaluated targets an enzyme in our cells regulating cholesterol, not the bacteria,” Carlyon said. “I do not envision the pathogens being able to develop resistance to this treatment because it is targeting a host pathway that they very much need to grow and survive inside of the body.”
The Latest on: Alternative to antibiotics
via Google News
The Latest on: Alternative to antibiotics
- New antimicrobial polymers as alternatives to antibioticson January 25, 2021 at 1:23 am
New Emmy Noether group at the University of Potsdam conducts joint research with Fraunhofer IAP On January 1, 2021, the new Emmy Noether Group "Next Generation Antimicrobial Polymers" started its work ...
- As More Bacteria Grow Resistant to Antibiotics, Scientists are Fighting Backon January 21, 2021 at 9:04 am
Scottish bacteriologist Alexander Fleming's discovery of penicillin, the world's first antibiotic, saved countless lives. But even as the bacteria ...
- Oxford animal-only antibiotic lab could prop up intensive farming, critics sayon January 20, 2021 at 4:30 am
New research centre to tackle overlap of livestock and human medicines, but campaigners fear “techno-fix” for factory farming ...
- Fighting antibiotic resistant superbugs with viruseson January 19, 2021 at 2:41 pm
There's been advances in the fight to combat antibiotic resistant superbugs. One of the Australian scientists at the forefront of this research Jeremy Barr of Monash University talks to Jesse about ...
- Antibiotic overuse in children's hospitals is leading to more 'superbug' infections in kidson January 19, 2021 at 8:37 am
Doctors acknowledge that antibiotics are overprescribed. The pandemic is just making the problem worse, they say. Overuse of antibiotics leads to increases in infection from antibiotic-resistant ...
- Taurine Trains Microbiota to Resist Invading Bacteriaon January 18, 2021 at 6:50 pm
Scientists find that the nutrient taurine, which helps the body digest fats and oils, could offer treatment benefit.
- Meet the scientist who defeated ‘the world’s worst bacteria’ to save her husband’s lifeon January 15, 2021 at 4:31 am
As she told us on the Science Focus Podcast, Professor Steffanie Strathdee tackled a superbug as it threatened to kill her partner.
- EPA approves aldicarb to help in Florida citrus's HLB fighton January 14, 2021 at 7:13 pm
The U.S. EPA on Jan. 12 announced it had approved the insecticide aldicarb, which combats the HLB-spreading Asian citrus psyllid.
- If in doubt, don’t! The dangers around antibiotic resistance in horses *H&H Plus*on January 14, 2021 at 7:00 am
Antibiotics – more correctly termed antimicrobials – have revolutionised the way we treat infectious disease, thanks to their ability to slow down or destroy the growth of bacteria. However, no one ...
- Our growing resistance to antibiotics may be an ongoing health threat.on January 14, 2021 at 4:51 am
By 2050, antibiotic resistance is predicted to cause millions of deaths per year and scientists are racing against time to find alternative treatments. Researchers are treating patients in a clinical ...
via Bing News